Portfolio company
Aelis Farma
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops pharmacological treatments for brain diseases including cannabis use disorders and cognitive deficits for patients with unmet medical needs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Pleo Pharma
This pharmaceutical company develops oral treatments to mitigate cannabis withdrawal symptoms for adult patients with cannabis use disorder.
Delix
This company develops non-hallucinogenic neuroplasticity-promoting medicines to treat neuropsychiatric and neurodegenerative conditions for patients with brain disorders.
Noema Pharma
This company develops clinical-stage therapeutic products for patients with central nervous system disorders and orphan neurological conditions.
IAMA Therapeutics
This company develops small molecule drugs to treat neurodevelopmental and central nervous system disorders for patients with autism and epilepsy.
Aeromics
This pharmaceutical company develops an intravenous drug to treat brain swelling in patients suffering from severe ischemic stroke.
Neuro3D SA
This company develops pharmaceutical treatments for central nervous system disorders such as schizophrenia and depression for the healthcare and medical research sectors.
Enemsa Pharma
This company develops small-molecule neuroprotective therapies and combination drugs to treat patients with rare neurodegenerative and cardiopulmonary diseases.
Sobrera Pharma
This pharmaceutical company develops medical treatments for patients suffering from alcohol use disorder and other addiction-related conditions.
